Arvind Utchanah - Net Worth and Insider Trading
Arvind Utchanah Net Worth
The estimated net worth of Arvind Utchanah is at least $60,359 dollars as of 2024-09-24. Arvind Utchanah is the Senior Officer of Knight Therapeutics Inc and owns about 10,213 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $60,359. Details can be seen in Arvind Utchanah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arvind Utchanah has not made any transactions after 2021-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arvind Utchanah
Arvind Utchanah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arvind Utchanah owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Arvind Utchanah’s form 4 insider trades.
Insider Ownership Summary of Arvind Utchanah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2021-09-21 | Senior Officer |
Arvind Utchanah Latest Holdings Summary
Arvind Utchanah currently owns a total of 1 stock. Arvind Utchanah owns 10,213 shares of Knight Therapeutics Inc (TSX:GUD) as of September 21, 2021, with a value of $60,359.
Latest Holdings of Arvind Utchanah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2021-09-21 | 10,213 | 5.91 | 60,359 |
Holding Weightings of Arvind Utchanah
Arvind Utchanah Form 4 Trading Tracker
According to the SEC Form 4 filings, Arvind Utchanah has made a total of 2 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Knight Therapeutics Inc is the acquisition of 300 shares on September 21, 2021, which cost Arvind Utchanah around $1,560.
Insider Trading History of Arvind Utchanah
- 1
Arvind Utchanah Trading Performance
GuruFocus tracks the stock performance after each of Arvind Utchanah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arvind Utchanah is 0.77%. GuruFocus also compares Arvind Utchanah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arvind Utchanah within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arvind Utchanah's insider trading performs compared to the benchmark.
Performance of Arvind Utchanah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.2 | | | | | |
| Relative Return to S&P 500(%) | -2.1 | | | | | |
Arvind Utchanah Ownership Network
Arvind Utchanah Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Arvind Utchanah is the Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Arvind Utchanah made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Arvind Utchanah Mailing Address
Above is the net worth, insider trading, and ownership report for Arvind Utchanah. Currently GuruFocus does not have mailing address information for Arvind Utchanah.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
